From a patient to discovery: a conventional approach to detection of unkown diseases and components of the biological systems


Cite item

Full Text

About the authors

Z S Barkagan

References

  1. Schmidt A. Die Lehre von den fermentativen Gerinnungserscheinungen in den eiweissartigen thierschen Korperfliissigkeiten. Dorpat: С Mattiesen; 1877.
  2. Morewitz P. Beitrage zur Kenntniss der Blutgerinnung 1 und 2 Mitteilunges. Dtsch. Arch. Klin. Med. 1903; 79: 1-28.
  3. Patek A. Y., Taylor F. H. L. Haemophilia, II. Some properties of a substance obtained from normal human plasma effective in accelerating the coagulation of hemophilic blood. J. Clin. Invest. 1937; 16 (1): 113-124.
  4. Pavlovsky A. Contribution to the pathogenesis of hemophilia. Blood 1947; 2: 185-191.
  5. Biggs R., Douglas A. S., Macfarlave R. G. et al. Christmas disease: a condition previously mistaken for haemophilia. Br. Med. J. 1952; 2: 1378-1382.
  6. Aggeler P. M., White S. G., Glendening M. B. et al. Plasma thromboplastin component (PTC) deficiency: a new disease resembling hemophilia. Proc. Soc. Exp. Biol.(N. Y.) 1952; 79: 692-694.
  7. Owren P. A. The coagulation of blood: investigation of a new clotting factor. Acta Med. Scand. 1947; suppl. 194: 1-327.
  8. Owren P. A. The fifth coagulation factor (factor V). Preparation and properties. Biochem. J. 1948; 43: 136-139.
  9. Dachlback В., Carlsson M. Familial thrombophilia due to a previously unrecognized mechanism characterized by resistance to activatged protein С Thromb. Haemost. 1993; 69 (suppl.): abstr. 988.
  10. Dachlback B. The discovery of activatged protein С resistance. J. Thromb. Haemost. 2003; 1 (1): 3-9.
  11. Bertina R. M., Koeleman B. P., Koster T. et al. Mutation in blood coagulation factor V associated with resistance to activated protein С Nature 1994; 369: 64-67.
  12. Svensson P. J., Dachlback B. Resistance to activated protein С as a basis for venous thrombosis. N. Engl. J. Med. 1994; 330: 517-522.
  13. Barkagan Z. S., Tsyvkina L. P., Mamaev A. N., Tseimakh I. A. Prevalence of APC-resistance among the patients with early thrombosis in the Siberian region of Russia. Thromb. Haemost. 1997; suppl.: 223, abstr. PS-206.
  14. Norstrom E., Thorelti E., Dachlback B. Functional characterization of recombinant FV Cambridge and FV Hong Kong. Blood 2002; 100: 524-530.
  15. Graham J. В., Barrow E. M., Hougie С Stuart clotting defect II. Genetic aspects of a "new" hemorhagic state. J. Clin. Invest. 1957; 36: 497-503.
  16. Tefler T. P., Denson K. W., Wright D. R. A "new" coagulation defect. Br. J. Haematol. 1956; 2: 308-316.
  17. Ratnoff O. D., Colopy J. E. A familial trait associated with deficiency of a clot-promoting fraction of plasma. J. Clin. Invest. 1955; 34 (4): 602-613.
  18. Egeberg O. Inherited antithrombin deficiency causing thrombophilia. Thromb. Diathes. Haemorrh. 1965; 13: 516-530.
  19. Баркаган 3. С., Бшиевский К. М., Суховеева Е. Я. Первичная тромбофилия, обусловленная дефицитом антитромбина III. Тер. арх. 1978; 8: 101-106.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2004 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 

Address of the Editorial Office:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

 © 2018-2021 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies